Clinical Trial Update: MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of a decitabine-genistein combination reports maximum tolerated dose determination and early signals of safety and efficacy in advanced solid tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Decitabine (Decitabine)
• Genistein (genistein)

Snippet

Sponsor: Uman Pharma | Conditions: Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED